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The effect of the dietary background of phyto-
estrogens on the outcome of rodent bioassays
used to identify and assess the reproductive
hazard of endocrine-disrupting chemicals is
controversial. Phytoestrogens, including genis-
tein, daidzein, and coumestrol, are fairly abun-
dant in soybeans and alfalfa, common
ingredients of laboratory animal diets. In fact,
soy and alfalfa are commonly used as protein
sources in the manufacture of most rodent
diets. Some of these ingredients are known to
contain endocrine modulators, such as the
phytoestrogens genistein and daidzein (abun-
dant in soybeans and its products) and their
respective glycosides (genistin and daidzin),
and coumestrol (found in alfalfa). These
phytoestrogens are able to bind to both estro-
gen receptor (ER) isoforms, ER-α and ER-β,
in vitro (Beck et al. 2003; Casanova et al.
1999). They have a higher affinity for ER-β
(Boue et al. 2003), but they activate both ER
isoforms, although with less potency than
estradiol. Both genistein and daidzein have
much weaker afﬁnities than does 17β-estradiol
for the rat ERs: genistein binds 3- and 100-
fold weaker, and daidzein binds 60- and
1,000-fold weaker to rat ER-β and ER-α,
respectively (Boue et al. 2003; Casanova et al.
1999). These two phytoestrogens are able to
elicit estrogenic responses in vivo (Boettger-
Tong et al. 1998; Brown and Setchell 2001;
Degen et al. 2002; Jefferson et al. 2002; Levy
et al. 1995; Odum et al. 2001; Thigpen et al.
1997). The selective interaction of phyto-
estrogens with human ER-α and ER-β is simi-
lar in vitro to that described for the rat
(Casanova et al. 1999; Kuiper et al. 1998).
Genistein is also known to have other activi-
ties, such as inhibition of different enzymes,
among them tyrosine kinases (Akiyama et al.
1987), nitric oxide synthase (Duarte et al.
1997), and topoisomerase II (Okura et al.
1988), and decreasing calcium-channel activ-
ity in neurons (Potier and Rovira 1999). It
also decreases lipid peroxidation (Arora et al.
1998) and diacylglycerol synthesis (Dean et al.
1989). Therefore, the multiple biologic activi-
ties of phytoestrogens raise the question of
whether they have the potential to inﬂuence
the outcome and/or interpretation of bioassays
used to identify chemicals with estrogenic
potential. In particular, questions have been
raised about the presence of phytoestrogens in
diets fed to animals used in bioassays designed
to screen chemicals that may act as weak regu-
lators of ERs and to screen low doses of
potent regulators of ERs (Thigpen et al. 1997,
2002). One such bioassay is the uterotrophic
assay, designed to evaluate both ER agonists
and antagonists.
By using a version of the uterotrophic assay
in the immature rat, one of the tier I screening
assays recommended for detecting the estro-
genic properties of endocrine-disrupting
chemicals [Organisation for Economic
Co-operation and Development (OECD)
2001; U.S. Environmental Protection Agency
(U.S. EPA) 1998], we have identiﬁed a set of
genes from the uterus and ovaries of prepu-
bertal rats for which expression is regulated
by estrogen exposure in a dose-dependent
manner and which have the potential to be
used as biomarkers for estrogen activity
(Naciff et al. 2003). Gene expression changes
induced by estrogen stimulation are more
sensitive than the classical end points (i.e.,
uterine weight increase) for evaluating estro-
genicity (Naciff et al. 2003). Given that com-
ponents of the rodent diet commonly used in
reproductive toxicology studies include chem-
icals with known estrogenic activity, under-
standing the influence of diet and dietary
components on estrogen response is an
important issue. In this study, we used gene
expression profiling to evaluate the effect of
two diets with different phytoestrogen con-
tent on the transcript profile of two organs
that are responsive to estrogen stimulation:
the uterus and the ovaries of prepubertal rats.
Materials and Methods
Chemicals. 17α-Ethynyl estradiol (EE) and
peanut oil were obtained from Sigma
Chemical Company (St. Louis, MO).
Animals and treatments. Fifteen-day-old
female Sprague-Dawley rats were obtained
(Charles River VAF/Plus; Charles River
Laboratories, Raleigh, NC) in groups of
10 pups per surrogate mother. We chose this
rat strain because it is commonly used in
reproductive and developmental toxicity stud-
ies. The rats were acclimated to the local vivar-
ium conditions (24°C; 12-hr light/12-hr dark
cycle) for 5 days and were fed a casein-based
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The effect of the dietary background of phytoestrogens on the outcome of rodent bioassays used to
identify and assess the reproductive hazard of endocrine-disrupting chemicals is controversial.
Phytoestrogens, including genistein, daidzein, and coumestrol, are fairly abundant in soybeans and
alfalfa, common ingredients of laboratory animal diets. These compounds are weak agonists for the
estrogen receptor (ER) and, when administered at sufficient doses, elicit an estrogenic response
in vivo. In this study, we assessed the potential estrogenic effects of dietary phytoestrogens at the
gene expression level, together with traditional biologic end points, using estrogen-responsive tissues
of the immature female rat. We compared the gene expression proﬁle of the uterus and ovaries, as a
pool, obtained using a uterotrophic assay protocol, from intact prepubertal rats fed a casein-based
diet (free from soy and alfalfa) or a regular rodent diet (Purina 5001) containing soy and alfalfa.
Estrogenic potency of the phytoestrogen-containing diet was determined by analyzing uterine wet
weight gain, luminal epithelial cell height, and gene expression proﬁle in the uterus and ovaries.
These were compared with the same parameters evaluated in animals exposed to a low dose of a
potent ER agonist [0.1 µg/kg/day 17α-ethynyl estradiol (EE) for 4 days]. Exposure to dietary phyto-
estrogens or to a low dose of EE did not advance vaginal opening, increase uterine wet weight, or
increase luminal epithelial cell height in animals fed either diet. Although there are genes whose
expression differs in animals fed the soy/alfalfa-based diet versus the casein diet, those genes are not
associated with estrogenic stimulation. The expression of genes well known to be estrogen regulated,
such as progesterone receptor, intestinal calcium-binding protein, and complement component 3, is
not affected by consumption of the soy/alfalfa-based diet when assessed by microarray or quantita-
tive reverse transcriptase–polymerase chain reaction analysis. Our results indicate that although diet
composition has an impact on gene expression in uterus and ovaries, it does not contribute to the
effects of an ER agonist. Key words: 17α-ethynyl estradiol, gene expression proﬁling, immature rat
uterotrophic assay, microarrays, phytoestrogens, rodent diet. Environ Health Perspect 112:1519–1526
(2004). doi:10.1289/ehp.6848 available via http://dx.doi.org/ [Online 16 August 2004]diet (soy- and alfalfa-free diet; Purina 5K96,
Purina Mills, St. Louis, MO). Starting on post-
natal day (PND)20 and during the experimen-
tal phase of the protocol, all rats were singly
housed in 20 × 32 × 20 cm plastic cages. To
test the diet effect, there were two animal
groups (n = 20): one group was fed a standard
laboratory rodent diet (Purina 5001, Purina
Mills), and the other group was maintained on
the casein-based diet. The Purina 5001 diet
contains phytoestrogens, mostly genistein and
daidzein derived from soy and alfalfa, at levels
that may have an impact on the gene expres-
sion profile (total daidzein + genistein =
0.49 mg/g; Thigpen et al. 1999), particularly
in tissues regulated by estrogens such as repro-
ductive tissues. However, those levels are not
uterotrophic when evaluated by the traditional
end points, uterine weight gain and increase in
luminal epithelial cell height. The casein-based
diet is essentially phytoestrogen free, consis-
tently containing < 1 ppm aglycone equivalents
of genistein, daidzein, and glycitein, and was
fed to the four groups of animals from PND16
onward in order to remove any possible effects
of the regular rodent diet (Purina 5001) previ-
ously fed to the rats by the animal supplier. All
the animals were allowed free access to water
and speciﬁc pelleted commercial diet (Purina
5001 or casein-based 5K96). The experimental
protocol was carried out according to Procter
and Gamble’s animal care approved protocols,
and animals were maintained in accordance
with the NIH Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory
Animal Resources 1996).
Starting on PND20, each diet group was
divided into two subgroups of 10 animals. One
subgroup from each diet subgroup was dosed
by subcutaneous injection with 0.1 µg/kg/day
EE in peanut oil. This dose is not sufﬁcient to
induce a uterotrophic response in juvenile rats
(Kanno et al. 2002; Naciff et al. 2003).
Animals received 5 mL/kg body weight of dose
solution once a day for 4 days. A 4-day dosing
regime was selected to optimize detection of
any effect of EE exposure at this low dose, both
at the histologic level and at the gene expres-
sion level. The dose was administered between
0800 and 0900 hr each day. Controls, fed with
the appropriate diet, received 5 mL/kg of
peanut oil once a day for 4 days. Doses were
administered on a microgram per kilogram
body weight basis and adjusted daily for weight
changes. Body weight (nearest 1.0 g) and the
volume of the dose administered (nearest
0.1 mL) were recorded daily. The exact time of
the last dose was recorded, to establish a 24-hr
waiting period before tissue collection. The
animals were sacrificed by CO2 asphyxiation
24 hr after the last dosing, on PND24. The
body of the uterus, cut just above its junction
with the cervix, with the ovaries attached, was
carefully dissected free of adhering fat and
mesentery and was weighed as a whole. Then,
the ovaries were dissected free, and the uterine
and ovarian wet weight was recorded. Both the
uterus and ovaries were placed into RNAlater
(50–100 mg/mL of solution; Ambion, Austin,
TX) at room temperature.
Histology. Reproductive tissues from two
animals in each dose group were ﬁxed in 10%
neutral buffered formalin immediately after
weighing and then dehydrated and embedded
in parafﬁn. Serial 4–5 µm cross sections were
made through the ovaries, oviducts, and uter-
ine horns, which were stained with hema-
toxylin and eosin. The evaluation of the
morphologic changes induced by the two dif-
ferent diets with or without EE exposure in the
uterus was performed as described previously
(Naciff et al. 2003).
Expression proﬁling. We used 10 µg total
RNA, extracted from uterus and ovaries from
individual animals (combining only the tissues
from the same animal), to prepare biotin-
labeled cRNA, as previously described (Naciff
et al. 2002, 2003). Labeled cRNA samples were
hybridized to the Affymetrix GeneChip Test 3
Array (Affymetrix Inc., Santa Clara, CA) to
assess the overall quality of each sample. After
determining the target cRNA quality, we
selected individual samples of pooled
uteri/ovaries from ﬁve or six individual females
(replicates) from each diet group, from con-
trols, and from EE-treated subgroups (with
high quality cRNA) and hybridized them to
Affymetrix Rat Genome U34A high-density
oligonucleotide microarrays for 16 hr. The
microarrays were washed and stained by strep-
tavidin-phycoerythrin to detect bound cRNA.
The signal intensity was ampliﬁed by second
staining with biotin-labeled anti-streptavidin
antibody and followed by streptavidin-phyco-
erythrin  staining. Fluorescent images were
read using the Hewlett-Packard G2500A gene
array scanner (Affymetrix Inc.). Affymetrix
image ﬁles for the 20 chip hybridizations, and
the absolute analysis results of each diet group
are available from the authors upon request.
Real-time reverse transcriptase-polymerase
chain reaction. In order to corroborate the
changes in gene expression identified by the
oligonucleotide microarrays, we used a real-
time (kinetic) quantitative reverse transcriptase-
polymerase chain reaction (QRT-PCR)
approach, as previously described (Naciff et al.
2002). This approach allowed us to evaluate the
“basal level” of expression of individual genes in
samples derived from animals exposed to the
two different diets used in our study, as well as
changes induced by low-dose EE exposure
(0.1 µg/kg/day). We compared the transcript
level of selected genes in samples derived from
animals in all experimental groups. To conﬁrm
the ampliﬁcation speciﬁcity from each primer
pair, the amplified PCR products were size-
fractioned by electrophoresis in a 4% agarose
gel in Tris borate ethylene diamine tetraacetic
acid buffer and photographed after staining
with ethidium bromide. Table 1 shows the
nucleotide sequences for the primers used to
test the indicated gene products. Preliminary
experiments were done with each primer pair to
determine the overall quality and speciﬁcity of
the primer design. After QRT-PCR, we
observed only the expected products at the cor-
rect molecular weight.
Data analysis. We addressed potential
interindividual variability by using indepen-
dent samples of each experimental group
(n = 5 for each set) for analysis. For the uter-
ine/ovarian weight determination, the luminal
epithelial cell height, and the gene expression
analysis, we compared the data from the ani-
mals fed with the casein-based diet with the
data from the animals fed the normal rodent
diet (Purina 5001). For gene expression analy-
sis, scanned output ﬁles of Affymetrix micro-
arrays were visually inspected for hybridization
artifacts and then analyzed using Affymetrix
Microarray Suite (version 5.0) and Data
Mining Tool (version 3.0) software, as
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Table 1. Primers used to verify the array-based gene expression changes induced by the two different diets, by QRT-PCR.
GenBank  Amplicon
Gene name accession no.a Forward primer Reverse primer size (bp)
Complement component 3 (CC3) M29866 5´-CGTGAGCAGCACAGAAGAGA-3´ 5´-CCAGGTGGTGATGGAATCTT-3´ 204
Progesterone receptor (PgR) L16922 5´-CATGTCAGTGGACAGATGCT-3´ 5´-ACTTCAGACATCATTTCCGG-3´ 428
Intestinal calcium-binding protein (icabp) K00994 5´-ATCCAAACCAGCTGTCCAAG-3´ 5´-TGTCGGAGCTCCTTCTTCTG-3´ 196
11-β-Hydroxylsteroid dehydrogenase type 2 (11βHSD) U22424 5´-ATGGCATTGCCTGACCTTAG-3´ 5´-CTCAGTGCTCGGGGTAGAAG-3´ 194
Vascular α-actin (VaACTIN) X06801 5´-GACACCAGGGAGTGATGGTT-3´ 5´-GTTAGCAAGGTCGGATGCTC-3´ 202
Cyclophilin B  AF071225 5´-CAAGCCACTGAAGGATGTCA-3´ 5´-AAAATCAGGCCTGTGGAATG-3´ 239
Cytochrome P450 subfamily XVII (Cyp17) M21208 5´-AAGTGGATCCTGGCTTTCCT-3´ 5´-CAATGCTGGAGTCGACGTTA-3´ 211
AA924771 EST Rattus norvegicus AA924772 5´-TTTGCTGTGCATGGGATTTA-3´ 5´-CCCTGCAGGATGTGAGAAGT-3´ 202
aFrom GenBank (2004).described by the manufacturer (Affymetrix
2002; Lockhart et al. 1996). Arrays were
scaled to an average intensity of 1,500 units
and analyzed independently. The Affymetrix
Rat Genome U34A microarrays used in this
study have 8,740 probe sets corresponding to
approximately 7,000 annotated rat genes and
1,740 expressed sequence tags (ESTs).
For each transcript in the diet and dose
groups, we conducted pairwise comparisons
with vehicle controls fed the casein-based diet,
using two-sample t-tests: first, we compared
the two diet groups, and then we compared
each treatment group with its respective diet
control. We then conducted analysis of vari-
ance (ANOVA) for general diet and treatment
effects on the signal value (which serves as a rel-
ative indicator of the level of expression of a
transcript) and the log of the signal value.
General diet effects were evaluated by ANOVA
and a nonparametric test for dose–response
trend, the Jonkheere-Terpstra test. Genes for
which any of the tests had p ≤ 0.001 was taken
as evidence that the expression of those genes
was modiﬁed by the diet or by EE exposure.
For the combined analysis of the two sets
(casein-based or Purina 5001 diet), stratiﬁed
nonparametric tests were conducted that were
focused in detecting genes showing a diet
response, or where there was a consistent treat-
ment effect versus vehicle for the EE-treated
group (0.1 µg kg/day). Here, we used linear
models, with terms for both study and treat-
ment effects, on average differences (signal val-
ues) and their log transformation, as well as
stratified forms of the Wilcoxon-Mann-
Whitney nonparametric statistic and a stratiﬁed
form of the Jonkheere-Terpstra nonparametric
statistic for diet response. Fold-change sum-
mary values for genes were calculated as a
signed ratio of mean signal values (for each diet
and EE-treated group compared with the
appropriate control). Because fold-change val-
ues can become artiﬁcially large or undeﬁned
when mean signal values approach zero, all the
values < 100 were made equal to 100 before
calculating the mean signal values that are used
in the fold-change calculation. All statistical
analyses use the measured signal values, even if
they were smaller than 100 units.
Results
Effect of diet on uterine/ovarian and uterine
wet weight and uterine luminal epithelial cell
height. Both diets, Purina 5001 and casein-
based 5K96, were well tolerated by all the ani-
mals. We observed no evidence of overt
toxicity and no clinical signs of toxicity. No
difference was determined in body weights
between animals fed either diet (Table 2). We
did not detect premature vaginal opening in
any of the animals in either diet group or in
animals exposed to EE. There were no differ-
ences in wet uterine weight or in absolute and
relative uterine weight (Table 2) between the
two diet groups, even when the animals were
exposed to low doses of EE.
The gross anatomy of the uterus and
ovaries of animals fed either diet was identical,
and no signs of accumulation of fluid in the
uterine lumen were noted in any of the animals.
We observed no differences in uterine weight
gain (wet weight) or uterine epithelial cell
height (Figure 1), and we found no change in
the number of uterine glands. The classical
morphologic changes induced by estrogen stim-
ulation (hypertrophy of luminal epithelial, stro-
mal, and myometrial cells; thickening of
stromal layer; and some stromal inﬂammatory
reaction) were not observed in any of the ani-
mals exposed to the two different diets, even
when exposed to 0.1 µg kg/day EE (Figure 1).
Effect of diet on gene expression proﬁle of
the uterus/ovaries. In order to compare the
gene expression proﬁles induced by the differ-
ent diets (different phytoestrogen content) and
the EE dose tested, we compared the average
value of the signal values, a relative indicator
of the level of expression of a transcript,
between the two groups of independent con-
trols. We then compared the appropriate
diet-control group with the respective EE
group (0.1 µg/kg/day), for all the 8,740 tran-
scripts represented on the array.
In comparing the expression proﬁle identi-
fied in the uterus/ovaries of animals fed a
casein-based diet versus the ones fed a
soy/alfalfa-containing diet, we identified the
expression of 29 genes that were signiﬁcantly
different (p ≤ 0.001). A list of those genes,
along with their accession numbers, gene sym-
bols, and the average fold changes, is shown in
Table 3. The number of genes whose expres-
sion is modiﬁed by the diet’s composition is
relatively small, and the average fold change
on the expression of these genes affected by
the rodent standard diet, compared with the
casein-based diet, is relatively low in the uterus
and ovaries. Although robust expression differ-
ences for specific genes can be attributed to
the composition of the diet, this list does not
include genes well known to be estrogen regu-
lated, such as progesterone receptor (PgR),
intestinal calcium-binding protein (icabp), and
complement component 3 (CC3).
One hypothesis is that if the soy/alfalfa-
based diet was not estrogenic on its own, per-
haps it would have sufficient potency to
measurably enhance the effect of a sub-
uterotrophic dose of EE. Although the expres-
sion of most genes from the prepubertal
uterus/ovaries that respond to estrogen expo-
sure is not altered by the diet composition,
there are some that show a variable, nonstatisti-
cally signiﬁcant response. For comparison, we
calculated the relative fold change induced by
diet for genes that showed a clear dose response
to 1–10 µg kg/day EE (Naciff et al. 2003).
Presumably, those genes have the potential to
represent the response to weak or low levels of
estrogen stimulation (expected from the dietary
phytoestrogens) and are shown in Table 4. The
fold change represents the ratio of the relative
expression level of each gene in tissues from
animals fed Purina 5001 versus those fed the
5K96 diet (as indicated in Table 3). For com-
parison, in Table 4 the relative expression level
of the same transcripts under EE exposure is
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Environmental Health Perspectives • VOLUME 112 | NUMBER 15 | November 2004 1521
Table 2. Diet effect on body, uterine, and ovarian weight and luminal epithelial cell height of the juvenile (PND24) rat.
Casein-based diet (5K96) Purina 5001 diet
Body Ovarian Uterine  Epithelial cell Body Ovarian Uterine Epithelial cell
weight weight weight height weight weight weight height
(g) (mg) (mg) (µm) (g) (mg) (mg) (µm)
Peanut oil
Mean ± SD (absolute) 68.1 ± 4.8 32.0 ± 2.6 56.1 ± 8.2 13.3 ± 1.3 70.1 ± 4.9 34.8 ± 3.3 59.6 ± 10.8 14.0 ± 2.2
Mean ± SD (relative)a 0.50 ± 0.04 0.58 ± 0.04 0.49 ± 0.07 0.56 ± 0.08
p-Valueb 0.05 0.18 0.41 0.26
0.1 EE (µg/kg/day)
Mean ± SD (absolute) 68.5 ± 5.4 36.2 ± 2.1 61.9 ± 11.2 13.1 ± 1.6 71.1 ± 5.8 37.1 ± 1.8 66.4 ± 13.2 14.5 ± 1.3
Mean ± SD (relative)a 0.52 ± 0.1 0.93 ± 0.1 0.52 ± 0.1 0.93 ± 0.2
p-Valueb 0.05 0.14 0.36 0.18
During the experimental phase, PND20 female rats were fed with a standard laboratory rodent diet (Purina 5001) or with a soy- and alfalfa-free diet (casein-based diet, 5K96) for 5 days
(from PND20 to PND24). Epithelial cell height values were obtained from tissue sections from the midregion of each uterine horn, at equivalent areas, and with clear representation of
the epithelium lining the lumen along the uterus (as shown in Figure 1). Epithelial cell height was determined by obtaining ﬁve measurements from ﬁve areas from two animals for each
group. These values were used to determine the mean cell height SD for each treatment group, and the corresponding p-value. 
aRelative weight (mg/g body weight). bTwo-tailed t-test comparing 5K96 with Purina 5001, in control or treated animals; n = 15 for each diet group (controls) and n = 10 for EE-treated
groups.also shown. Analyzing the effect of EE expo-
sure on the expression of the same set of genes,
comparing the relative expression level of each
gene in the tissues from animals exposed to EE
versus their respective controls that were fed
the same diet, and taking into account that
lack of statistical significance for those genes
listed, the average (n = 5) response to EE expo-
sure is very similar, if not equal, even for those
showing a relative large fold change, regardless
of the diet fed to the animals. These results
suggest that the response to the diet’s composi-
tion is independent from the EE effect at this
dose level of exposure. At higher doses of EE,
the contribution of the dietary phytoestrogens
is considered negligible because EE is a potent
ER agonist able to interact with both isoforms
of this receptor and with higher afﬁnity than
any of the dietary phytoestrogens (Kuiper et al.
1997). The changes induced by exposure to
higher EE doses have been reported (Naciff
et al. 2003). Corroboration of the microarray
results by QRT-PCR for a selected group of
genes is shown in Table 5. With the exception
of CC3, which is undetectable by microarray
analysis of samples derived from the animals
exposed to two different diets (Table 5), the
expression levels of the other genes are very
similar, determined by either QRT-PCR or
microarray analysis.
Discussion
Dietary phytoestrogens, such as genistein and
daidzein (abundant in soybeans and its prod-
ucts) and their respective glycosides (genistin
and daidzin), and coumestrol (found in
alfalfa), have been found to have estrogenic
properties in both in vitro and in vivo (Beck
et al. 2003; Boettger-Tong et al. 1998; Boue
et al. 2003; Brown and Setchell 2001;
Casanova et al. 1999; Degen et al. 2002;
Jefferson et al. 2002; Kanno et al. 2002; Levy
et al. 1995; Odum et al. 2001; Thigpen et al.
2002). However, the results of the present
study showed that phytoestrogens at concen-
trations present in a given lot of a commercial
rodent diet are not able to elicit an estrogenic
response in the reproductive system of the
immature rat, judged by classical end points
and specific gene expression changes charac-
teristic of estrogen exposure in estrogen-
responsive target organs (uterus and ovaries).
Although a number of gene expression differ-
ences were observed with the two rodent diets
tested, Purina 5001 and casein-based diet (rela-
tively high vs. low phytoestrogen content,
respectively), they cannot be correlated with
estrogenic activity. These gene expression
changes are more likely to be caused by nutri-
tional differences between the diets, rather than
individual dietary components affecting ER
pathways. Also, the traditional end points used
to assess estrogenic activity, namely, uterine
wet weight gain and hypertrophy of luminal
epithelial cell layer, were not affected by the
phytoestrogen content of the diet. It has to be
stressed that we have previously identiﬁed gene
expression as being far more sensitive than the
classical uterotrophic response in assessing
estrogenicity (Naciff et al. 2003).
We also tested whether the consumption
of phytoestrogen-containing diets was suffi-
cient to render a subuterotrophic dose regi-
men of EE active. To do this, we evaluated the
number and type of genes whose expression is
modified in the uterus/ovaries from animals
exposed to 0.1 µg/kg/day EE but fed different
diets. There is not a statistically different num-
ber of genes affected by components of the
diet, and those genes affected by EE are the
same, regardless of the diet fed to the animals.
More important, the different phytoestrogen
content of the diets does not modify—by
either increasing or decreasing—the response
of the estrogen-sensitive genes from the
uterus/ovaries to low doses of a potent ER
agonist; their expression changes in the same
direction and magnitude as a result of EE
regardless of whether the rats were fed the
phytoestrogen-containing diet. Table 4 shows
the transcripts that we have previously identi-
ﬁed as being responsive to estrogen exposure,
under the uterotrophic assay protocol (Naciff
et al. 2003), with their relative expression level
calculated by comparing the two diets. This
includes genes that have an extremely robust
response to estrogen exposure, such as CC3,
PgR, and icabp (Heikaus et al. 2002; Krisinger
et al. 1992; L’Horset et al. 1990; Li et al.
2002; Naciff et al. 2003). Thus, we are conﬁ-
dent that, despite the potential effect of the
phytoestrogens in the Purina 5001 diet, the
transcript proﬁle determined in the uterus and
ovaries is comparable with the one determined
in the animals fed the casein-based diet, and
truly reﬂects the lack of estrogenic activity of
the soy/alfalfa-based diet.
Our data corroborate the findings of the
OECD (Owens et al. 2003), Wade et al.
(2003), and Yamasaki et al. (2002) in the
uterotrophic assay. As part of the studies con-
ducted by the OECD validation initiative, it
has been established that the phytoestrogen
contents of the multiple rodent diets employed
by the participant laboratories had no impor-
tant effect on the sensitivity of the uterotrophic
assay (Owens et al. 2003). In independent
studies, Wade et al. (2003) and Yamasaki et al.
(2002) reached the same conclusions by testing
the effect of various phytoestrogen-containing
diets in the outcome of their immature
uterotrophic assays. Our findings also agree
with reports on the effects of phytoestrogens
on the reproductive system of other species.
Foth and Cline (1998) reported that supple-
menting the diet of postmenopausal macaques
with up to 148 mg of phytoestrogen (from
soy) per day for 6 months failed to induce any
proliferative effects on endometrial histology, a
marker for estrogenic stimulation. Anthony
et al. (1996) determined that dietary soybean
isoﬂavones improve cardiovascular risk factors
(plasma lipids, lipoproteins, and atherosclerosis)
without detectable estrogenic effects in the
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Figure 1. Representative uterine transversal sections from equivalent regions of vehicle-treated control
immature rats (PND24; A, B, E, F) or animals treated with 0.1 µg/kg/day EE (C, D, G, H) fed with a casein-
based diet (5k96; A, C, E, G) or a standard rodent diet (Purina 5001; B, D, F, H). Abbreviations: g, gland; Le,
uterine lumen. See “Materials and Methods” for details. The rodent diet (B, D, F, H) containing quantiﬁable
amounts of phytoestrogens did not have an impact on the histologic characteristics of the uterus, com-
pared with tissues obtained from animals fed a relatively phytoestrogen-free casein-based diet (A, C, E, G).
Bar = 0.08 mm for A–D; bar = 0.01 mm for E–H.reproductive system of peripubertal rhesus
monkeys. The data presented here establish the
fact that the phytoestrogens found in a regular
Western diet (compared with traditional Asian
diets), exempliﬁed here as the standard rodent
diet, do not elicit an estrogenic response at the
histologic level or at the gene expression level.
Thus, the potential beneﬁts for humans derived
from consuming a normal diet (not intention-
ally enriched with phytoestrogens) are not com-
promised by undesired estrogenic properties.
These findings demonstrate that the
phytoestrogens present in a regular rodent diet
do not affect the biologic response to a potent
exogenous ER agonist, at the level of tissue
architecture or gene expression, in prepubertal
rat uterus and ovaries. From the results of the
present study, it is clear that in order to elicit
an estrogenic response at the gene expression
level, the organism has to be exposed to higher
concentrations of phytoestrogens, as has been
shown in the developing female rat with pure
genistein (Jefferson et al. 2002; Naciff et al.
2002). It must be stressed that the route of
administration has an impact on the degree of
the response; Ashby (2000) has shown that
genistein gives a stronger uterotrophic
response in the immature mouse when subcu-
taneously injected than when given orally at
equivalent concentrations.
Some of the gene expression changes
attributed to the composition of the diet,
determined in the present study, may have an
impact on the biologic response of the repro-
ductive system (uterus/ovaries), mostly by
inﬂuencing various pathways, some of which
have an effect on sex hormone axis. However,
none of these genes was included in the tran-
script proﬁle determined for estrogens in the
immature rat uterus and ovaries (Naciff et al.
2003). For example, rGrb14, the rat homo-
logue of the human growth factor receptor,
bound human Grb14 adaptor protein, a direct
inhibitor of the activated insulin receptor
(Bereziat et al. 2002; Kasus-Jacobi et al. 1998),
whose up-regulation may result in modiﬁcation
of the response of the uterus/ovaries to insulin.
Another gene whose expression is modiﬁed by
the composition of the diet is that of the
gonadotropin-releasing hormone receptor,
which among other activities regulates gameto-
genic and hormonal functions of the gonads
(Kang et al. 2003). The expression of insulin-
like growth factor 1 (IGF-1) is up-regulated in
the reproductive tissues of animals fed the diet
with a relatively high phytoestrogen content
(Table 3). IGF-1 is a critical regulator of uter-
ine growth, and locally produced uterine
IGF-1 could mediate the effects of estradiol on
growth and cellular proliferation (Sato et al.
2002). The expression of the gene encoding
steroid 3-α-dehydrogenase is also up-regulated
by the soy/alfalfa-based diet. This enzyme, a
member of the aldo-keto reductase gene
superfamily, is an important multifunctional
oxidoreductase capable of metabolizing steroid
hormones, polycyclic aromatic hydrocarbons,
and prostaglandins (Huang and Luu-The
2000). Aquaporin 1 (AQP1) is one of the
genes for which expression is down-regulated
by a soy/alfalfa-based diet. This gene encodes a
protein that is a member of a family of mem-
brane channel proteins which facilitate bulk
water transport and possibly other small mole-
cules, the aquaporins. Treatment of adult
ovariectomized mice with replacement steroids
demonstrates an estrogen-induced shift in
AQP1 signals from the myometrium to the
uterine stromal vasculature, suggesting a role
in uterine fluid inhibition (Richard et al.
2003), one of the physiologic responses of the
uterus to estrogen stimulation. However, the
relative expression level of AQP1 gene was
not determined by Richard et al. (2003). Li
et al. (1997) described a stimulatory effect of
estradiol at relatively high concentrations
(40 µg/kg) in the expression level of an aqua-
porin gene (AQP-CHIP) in the uterus of
immature rats, although this gene was not
identiﬁed as AQP1. However, the response of
AQP1 in the immature uterus of the rat to
dietary components is actually a decrease in
its expression level, opposite the effect of
estrogenic stimulation.
In all, our data indicate that although
there is a clear effect of the diet of the gene
Article | Rodent diet and expression profiling in reproductive tissues
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Table 3. Genes whose expression is modiﬁed by exposure to diet in the uterus/ovaries of the immature rat.
GenBank Gene Average
accession no.a Gene name symbol fold changeb p-Valuec
X67948 Aquaporin 1 (aquaporin channel forming integral protein)  AQP1 1.6 0.000159
U56839 Purinergic receptor P2Y, G-protein coupled 2  P2ry2 1.4 0.000448
AF017756 GSK-3beta interacting protein rAxin  Axin 1.4 0.000130
AA859529 Diacylglycerol acyltransferase  Dgat 1.3 0.000470
L06096 Inositol 1,4,5-triphosphate receptor 3  Itpr3 1.3 0.000420
U90887 Arginase type II  Arg2 1.3 0.000728
U78977 ATPase, class II, type 9A Atp9a 1.3 0.000022
AA892562 EST196365, high homology to nucleolar protein NAP57 and dyskeratosis congenita 1, dyskerin  Dkc1 1.3 0.000747
AI639534 ESTs, similar to properdin (factor P) 1.3 0.000446
AI231213 ESTs, high homology to kangai 1 (suppression of tumorigenicity 6), prostate  Kai1 1.2 0.000561
D10874 Vacuolar H(+)-transporting ATPase,  1.2 0.000865
X56133 Mitochondrial H+-ATP synthase alpha subunit  Atp5a1 –1.1 0.000854
D13417 Transcription factor HES-1 homolog of hairy and enhancer of split 1, (Drosophila)  Hes1 –1.2 0.000045
Z71925 Polymerase (RNA) II (DNA directed) polypeptide G  Polr2g –1.2 0.000379
AA818487 ESTs, high homology to cyclophilin B  Ppib –1.2 0.000253
AI112237 ESTs, moderately similar to JE0384 NADH dehydrogenase  –1.2 0.000192
AA818858 Peptidylprolyl isomerase A (cyclophilin A)  Ppia –1.3 0.000943
AA686579 ESTs, similar to ubiquitin-like protein SMT3C precursor  –1.3 0.000954
U64705 Protein synthesis initiation factor 4AII gene and E3 small nucleolar RNA gene –1.3 0.000405
S69316 GRP94/endoplasmin (5 and 3 regions) –1.3 0.000120
M15481 Insulin-like growth factor 1  IGF-1 –1.3 0.000068
S69315 GRP94/endoplasmin (5 and 3 regions)  –1.4 0.000174
D17310 3-alpha-Hydroxysteroid dehydrogenase (3-alpha-HSD) –1.4 0.000397
X67859 Autoantigen or Sjogren syndrome antigen B Ssb –1.4 0.000103
AA685903 ESTs, similar to glucose regulated protein, 94 kDa GRP94 –1.5 0.000878
S68578 Gonadotropin-releasing hormone receptor  Grhr –1.5 0.000322
AI009141 EST203592, Rattus norvegicus –1.8 0.000468
AF076619 Growth factor receptor bound protein 14 or molecular adapter rGrb14 (Grb14), an inhibitor  Grb14 –2.1 0.000158
of insulin actions
aFrom GenBank (2004).bThe average fold change was determined by comparing the average signal value of the indicated transcripts obtained from the uterus/ovaries from ﬁve females
fed with the casein-based diet (5K96) versus the average signal value obtained from the same tissues from ﬁve females fed the standard rodent diet (Purina 5001). cTranscripts listed are
those showing a robust response to the different diet (p < 0.001) using the stratiﬁed form of the Jonkheere-Terpstra nonparametric statistic to identify the diet response. expression profile of the uterus/ovaries from
the immature rats, this effect is subtle and can-
not be correlated with the phytoestrogen con-
tent of each diet. Most of the gene transcripts
represented in the microarray used in this
study have an expression level that is very sim-
ilar in all the animals, regardless of their diet.
Further, by analyzing the expression levels of
known estrogen-regulated genes (Naciff et al.
2003), we determined that there is not a sig-
nificant difference in the relative expression
level of any of those genes between animals
exposed to Purina 5001 or casein-based diets.
In addition, we found no signiﬁcant changes
at the transcript level for selected estrogen-
regulated genes by QRT-PCR. Thus, we are
conﬁdent that—despite the potential effect of
the phytoestrogens in the diet of animals used
in a bioassay designed to evaluate the poten-
tial estrogenic activity of a given chemical—
the response to the chemical (which could be
the transcript proﬁle induced by exposure) is
independent of the diet and has the potential
to truly reﬂect estrogenic activity.
Article | Naciff et al.
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Table 4. Diet effect on genes whose expression is modiﬁed by exposure to of 0.1 µg/kg EE in the uterus/ovaries of the immature rat.
Average fold changeb
GenBank Gene Purina EE vs. control, EE vs. control, 
accession no.a Gene name symbol 5001/5K96 5K96 Purina 5001
M29866 Complement component 3 CC3 A 14.7 7.0
Y08358 Eotaxin or small inducible cytokine A11 Scya11 A 2.7 2.9
AI013389 ESTs, similar to calcium-binding protein, intestinal, vitamin D-dependent  Calb3 2.0 2.4 1.9
K00994 Intestinal calcium-binding protein icabp 1.1 5.2 2.1
U49062 CD24 antigen Cd24 1.1 1.3 1.2
L14004 Polymeric immunoglobulin receptor pigr 1.5 1.4 1.1
AA859661 ESTs, similar to glutaminyl-peptide cyclotransferase precursor A 2.1 1.7
M57718 Cytochrome P450 IV A1 CYP4A1 AAA
U22424 Hydroxysteroid dehydrogenase, 11-β type 2  Hsd11b2 1.0 2.2 1.6
L07114 Apolipoprotein B editing protein Apobec1 AAA
S79730 Opioid receptor-like ORL1 receptor Oprl1 1.2 1.3 1.4
M88469 f-Spondin Sponf 1.7 1.7 1.1
X66845 Dynein, cytoplasmic, intermediate chain 1 Dncic1 AAA
L46593 Small proline-rich protein gene Sprr 2.4 2.5 –1.0
L00191 Fibronectin, encoding three mRNAs, exons 1, 2, 3 fn –1.2 1.6 1.2
M22323 Gamma-enteric smooth muscle actin Actg2 1.4 1.5 1.3
D15069 Adrenomedullin Adm 1.9 2.4 1.2
AA893870 EST197673 Rattus norvegicus A 1.7 2.0
AI232078 Transforming growth factor-β (TGF-β) masking protein  Ltbp1 –1.1 1.2 1.1
U82612 Fibronectin (fn-1) gene fn-1 1.5 1.6 1.1
X05834 Fibronectin (fn-3) gene fn-3 1.0 1.4 1.2
L00382 Skeletal muscle β-tropomyosin and ﬁbroblast tropomyosin 1 tpm1 1.2 1.7 1.3
AA800908 EST190405 Rattus norvegicus 1.2 1.6 1.4
M25758 Phosphatidylinositol transfer protein Pitpn 1.1 1.3 1.3
AA799773 ESTs, Rattus norvegicus 1.3 1.3 1.2
AA892829 EST, similar to mouse bifunctional 3’-phosphoadenosine (PPS1) PPS1 1.2 1.3 1.1
AB010963 Potassium large conductance calcium-activated channel Kcnmb1 1.2 1.4 1.2
AF083269 Actin-related protein complex 1b Arpc1b 1.0 1.3 –1.0
AA891760 EST195563 Rattus norvegicus AAA
AJ005394 Collagen α 1 type V Col5a1 –1.1 1.6 1.2
L11930 Cyclase-associated protein homologue Cap1 1.1 1.3 1.2
X07467 Glucose-6-phosphate dehydrogenase G6pd 1.2 1.2 –1.1
U26310 Tensin Tns 1.2 1.3 1.1
AA891542 EST195345 Rattus norvegicus, similar to mouse heat shock protein hsp40-3 Dnajb5 1.3 1.3 1.1
U44948 Cysteine-rich protein 2 or smooth muscle cell LIM protein (SmLIM) Csrp2 –1.1 –1.6 –1.4
S61868 Ryudocan or heparan sulfate proteoglycan core protein or syndecan-4  SDC4 –1.2 –1.5 –1.1
L41254 Corticosteroid-induced protein or FXYD domain-containing ion transport regulator 4  Fxyd4 –1.1 –1.4 –1.1
AF023087 Nerve growth factor induced factor A, or early growth response 1 Egr1 –1.5 –1.7 1.1
U07181 Lactate dehydrogenase B Ldhb –1.3 –1.2 –1.1
X89225 Solute carrier family 3, member 2  Slc3a2 –1.3 –1.5 –1.3
AF054826 Vesicle-associated membrane protein 5  Vamp5 –1.2 –1.8 –1.2
X75253 Phosphatidylethanolamine binding protein  Pbp –1.2 –1.4 –1.1
AA924772 ESTs, similar to metallothionein 3 Mt3 AAA
AA894027 EST197830 Rattus norvegicus AAA
AA894030 EST197833 Rattus norvegicus AAA
AA946532 ESTs, similar to ATP-binding cassette, sub-family D (ALD), member 3  Abcd3 –1.3 –1.4 –1.3
M32754 Inhibin α-subunit Inha –1.3 –1.6 1.0
AA874794 ESTs, similar to nerve growth factor receptor (TNFRSF16) associated protein 1 Ngfrap1 1.0 –1.4 –1.2
M21060 Superoxide dismutase 1, soluble  Sod1 –1.2 –1.2 –1.2
X08056 Guanidinoacetate methyltransferase GAMT –1.2 –1.3 –1.0
D00729 δ3, δ2-enoyl-CoA isomerase  –1.2 –1.2 –1.3
U90829 APP-binding protein 1  Appbp1 –1.2 –1.6 –1.1
AI170613 ESTs, similar to heat shock 10 kDa protein 1 Hspe1 –1.2 –1.3 –1.6
D63761 Adrenodoxin reductase  Fdxr –1.1 –1.5 –1.1
D78303 Splicing factor YT521-B  YT521 –1.1 –1.2 –1.2
L48060 Prolactin receptor  Prlr 1.0 –1.3 –1.2
AA849036 ESTs, similar to guanylate cyclase 1, soluble, α-3  Gucy1a3 –1.2 –1.3 –1.1
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M33648 Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase  HMGCS2 –1.2 –1.6 –1.3
E05646 Phosphatidylethanolamine binding protein  Pbp –1.2 –1.3 –1.2
AA858520 ESTs, similar to follistatin  Fst –1.3 –1.5 –1.1
L02842 Follicle-stimulating hormone receptor  FSHR AAA
X04229 Glutathione-S-transferase, µ type 1 (Yb1) Gstm1 –1.2 –1.4 –1.2
L23148 Inhibitor of DNA binding 1, helix-loop-helix protein  Id1 1.0 –1.1 1.0
D63761 Adrenodoxin reductase  Fdxr 1.0 –1.4 –1.2
AF076619 Growth factor receptor bound protein 14  Grb14 –1.5 –1.8 –1.3
M33648 Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase  –1.3 –2.0 –1.6
AA858520 Follistatin  Fst –1.3 –1.4 –1.3
X62660 Glutathione transferase subunit 8 –1.2 –1.5 –1.3
AI175776 EST219344 Rattus norvegicus  –1.2 –1.7 –1.4
J03914 Glutathione-S-transferase, µ type 2 (Yb2)  Gstm2 –1.2 –1.2 –1.1
J02592 Glutathione-S-transferase, µ type 2 (Yb2)  Gstm2 –1.1 –1.3 –1.2
S59525 Gonadotropin-releasing hormone receptor grhr –1.1 –1.8 –1.4
M36453 Inhibin α Inha –1.2 –1.6 –1.6
X54793 Heat shock protein 60 (liver)  Hsp60 –1.3 –1.3 –1.6
AA858640 ESTs –1.2 –1.4 –1.4
L19998 Minoxidil sulfotransferase  PST-1 –1.2 –1.4 –1.4
X78848 Glutathione-S-transferase, α type (Ya)  Gsta1 –1.2 –1.5 –1.4
AF001898 Aldehyde dehydrogenase 1, subfamily A1  Aldh1a1 1.1 –1.5 –1.5
X97754 Hydroxysteroid dehydrogenase 17β, type 1  Hsd17b1 –1.5 –2.3 –1.6
AF000942 Inhibitor of DNA binding 3, dominant negative helix-loop-helix  Id3 –1.2 –1.3 –1.1
AI171268 EST217223 Rattus norvegicus, identical to inhibitor of DNA binding 3,  Id3 –1.4 –1.4 –1.1
dominant negative helix-loop-helix 
D84336 Delta-like homolog (Drosophila), a novel member of the epidermal growth factor  Dlk1 AAA
(EGF)-like family of proteins 
S63167 3 β-Hydroxysteroid dehydrogenase isomerase type II HSD3B2 –1.1 –1.4 –1.6
M12492 Type II cAMP-dependent protein kinase regulatory subunit prkar2a –1.3 –1.9 –1.8
S72505 Glutathione S-transferase Yc1 subunit –1.2 –1.5 –1.6
AA874919 Mismatch repair protein  Msh2 –1.1 –1.5 –1.1
M14656 Sialoprotein (osteopontin)  Spp1 1.0 –3.5 –2.4
X01115 SVS-protein F, or seminal vesicle secretion 5 Svs5 –1.4 –3.9 1.1
M21208 Cytochrome P450, subfamily XVII  Cyp17 1.1 –2.4 –2.2
A, absent (undetectable by Microarray Suite 5.0; Affymetrix). Transcripts listed are those previously reported to show a robust response to graded doses of EE in the uterotrophic assay
(p < 0.001) (Naciff et al. 2003); n = 5 per group.
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Table 5. Selected gene expression changes veriﬁed by QRT-PCR.
CC3 icabp 11βHSD PgR EST AA924772 VaACTIN Cyp17 Cyclo B
Treatment Q M Q M Q M Q M Q M Q M Q M Q M
Vehicle in Purina 5001 vs. 5K96 1.0 A 1.2 1.1 1.2 1.0 1.1 1.1 –1.1 A 1.2 1.1 –1.2 1.1 1.1 1.0
0.1 EE µg vs. control in 5K96 18.7 14.7 3.7 5.2 2.7 2.2 1.8 1.6 –1.5 A 1.1 1.0 –3.5 –2.4 1.0 1.1
0.1 EE µg vs. control in Purina 5001 21.2 7.0 3.3 2.1 2.9 1.6 2.2 1.5 –1.4 A 1.1 1.1 –3.4 –2.2 1.1 1.0
Abbreviations: 11βHSD, 11-β-hydroxylsteroid dehydrogenase type 2 gene; A, absent (undetectable by Microarray Suite 5.0; Affymetrix); cyclo B, cyclophilin B gene; Cyp17, cytochrome
P450 subfamily XVII gene; M, microarray-derived fold change; Q, QRT-PCR–derived fold change; VaACTIN, vascular α-actin gene. The relative fold change is the ratio of the relative
expression level of each gene in uterus/ovaries from animals fed Purina 5001 versus those fed 5K96 diet. The microarray-derived fold change and the QRT-PCR–derived fold change were
determined as described in “Materials and Methods,” using the same amount of total RNA derived from three independent animals, in duplicate. These genes were chosen on the basis of
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